| Biomarker ID | 1016 |
| PMID | 23119026 |
| Year | 2012 |
| Biomarker | Aldehyde Oxidase 1 (AOX1) |
| Biomarker Basis | Methylation Based |
| Biomolecule | Methylation |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Hypermethylation in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Nicotine metabolism, Nitric oxide effects, Vitamin B6 metabolism, Nicotinate and nicotinamide metabolism, Valine, leucine and isoleucine degradation |
| Experiment | Pca Tumor Vs Tumor Adjacent |
| Type of Biomarker | Diagnostic |
| Cohort | PCa (n=19) and adjacent normal tissues (n=4) were used for discovery, and validated on additional 56 PCa samples and 55 adjacent normal tissues. [Results for validation set] |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p = 7.46 x10^-8 |
| Method Used | Bisulfate Sequencing |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |